SIGI
ICCM icon

Susquehanna International Group (Ireland)’s IceCure Medical ICCM Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-507
Closed -$16.3K – 93
2023
Q4 		$16.3K Hold
507
– – ﹤0.01% 61
2023
Q3 		$8.43K Sell
507
-35
-6% -$1.1K ﹤0.01% 60
2023
Q2 		$18.9K Buy
+542
New +$19.4K 0.02% 56
2022
Q1 		– Sell
-423
Closed -$38K – 79
2021
Q4 		$38K Buy
+423
New +$70.7K 0.02% 61

Other funds holding ICCM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group (Ireland)'s ICCM Position: Q1 2024 in Review

Susquehanna International Group (Ireland) sold out of IceCure Medical (ICCM) in Q1 2024, closing a stake of 507 shares — an estimated $16.3K sold.

Susquehanna International Group (Ireland) first reported a position in ICCM in Q4 2021 and held it in 4 quarters. The position peaked at $38K in Q4 2021. 12 funds tracked by Wall St. Rank hold ICCM as of Q1 2024.

  • Susquehanna International Group (Ireland) reported no remaining IceCure Medical position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 507 IceCure Medical shares in Q1 2024, an estimated $16.3K.
  • Susquehanna International Group (Ireland) first reported a position in IceCure Medical in Q4 2021 and held it in 4 quarters.
  • Susquehanna International Group (Ireland)'s IceCure Medical position peaked at $38K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2024.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q1 2024, filed 7 May 2024.